Yubo International Biotech Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.156615 million compared to USD 0.015213 million a year ago. Net loss was USD 0.316667 million compared to USD 0.578948 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.59 USD | +18.26% | +180.95% | +96.67% |
1st Jan change | Capi. | |
---|---|---|
+96.67% | 70.69M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- YBGJ Stock
- News Yubo International Biotech Limited
- Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2023